# Phase 45B — Patient Journey Evidence Closeout Report

**Date:** 2026-06-02
**Mode:** Read-only closeout. No code changes. No deploy. No rebuild. No patient-journey replacement. No OTP/signing/public-signing API changes.

## 1. Controlling Evidence

This closeout adopts the following reports as the controlling evidence set:

- [phase41a-prior-patient-journey-e2e-evidence-reconciliation-report.md](./phase41a-prior-patient-journey-e2e-evidence-reconciliation-report.md)
- [phase41b-controlled-patient-delivery-unfreeze-decision.md](./phase41b-controlled-patient-delivery-unfreeze-decision.md)

Accepted controlling classification:

**PRIOR PATIENT JOURNEY E2E EVIDENCE FOUND AND STILL APPLICABLE**

## 2. Route Confirmation

The active patient route remains:

- [apps/web/app/sign/[token]/workflow/page.tsx](../../apps/web/app/sign/[token]/workflow/page.tsx)

Current route behavior:

- imports `ApprovedPatientWorkflow`
- validates the signing token through `getSigningTokenContext(token)`
- returns `notFound()` on invalid/expired token (`ApiError` 404)
- renders the patient journey inside `UIRefreshBoundary surface="public-signing"`

This confirms `/sign/[token]/workflow` remains the active patient-facing public-signing route.

## 3. Active Patient Component Confirmation

The active patient component remains:

- [apps/web/src/components/approved-design/patient/ApprovedPatientWorkflow.tsx](../../apps/web/src/components/approved-design/patient/ApprovedPatientWorkflow.tsx)

Current component contract remains consistent with the prior approved surface:

- 7-screen approved patient journey plus refusal branch
- real public-signing API wiring
- OTP-gated progression preserved
- no replacement by OneDrive/Figma mock port
- no rebuild or recovery required for patient-side source

## 4. Applicability of Prior E2E Evidence

Per [phase41a-prior-patient-journey-e2e-evidence-reconciliation-report.md](./phase41a-prior-patient-journey-e2e-evidence-reconciliation-report.md):

- prior production smoke evidence, Day-1 pilot execution evidence, and Day-1 monitoring evidence collectively proved the patient/public-signing flow
- the protected patient files were reconciled against the later production baseline and remained unchanged except for one localized SQL parameter-cast hardening in `signature-orchestration-service.ts`
- that hotfix was explicitly classified as non-behavioral with respect to the patient journey
- no new patient token issuance was required for reconciliation

Per [phase41b-controlled-patient-delivery-unfreeze-decision.md](./phase41b-controlled-patient-delivery-unfreeze-decision.md):

- the same patient protected-path set remained unchanged
- the same final classification was carried forward
- the prior E2E evidence remained valid for controlled pilot patient delivery

Therefore, the prior patient-journey E2E evidence remains applicable to the current patient journey surface.

## 5. Controlled Pilot Suitability

For the patient journey specifically, the following remain true:

- `/sign/[token]/workflow` is the active route
- `ApprovedPatientWorkflow.tsx` is the active mounted patient component
- the prior E2E evidence remains applicable
- the patient journey remains approved for controlled pilot use under the existing Phase 41A / 41B evidence basis
- no further patient-source recovery is required

Boundary note:

This closeout applies to the patient journey only. It does not reclassify or re-open any separate physician-route investigations.

## 6. Closeout Decision

Phase 45B objective is satisfied.

- Active patient route confirmed: yes
- Active patient component confirmed: yes
- Prior E2E evidence still applicable: yes
- Patient journey approved for controlled pilot use: yes
- Further patient source recovery required: no

## 7. Final Classification

**PATIENT JOURNEY EVIDENCE CLOSED – PRIOR E2E STILL APPLICABLE**
